ASHLEY LAY: Open Payments
NPI 1265188940 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 58 payments from 22 companies in 2025. Trend: 2023 $865 · 2024 $252 · 2025 $2,057
Food & beverage: $1,268Education: $789
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $527 |
| Janssen Biotech, Inc. | 12 | $321 |
| AstraZeneca Pharmaceuticals LP | 5 | $214 |
| E.R. Squibb & Sons, L.L.C. | 2 | $122 |
| Incyte Corporation | 2 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $93 |
| Aveo Pharmaceuticals, Inc. | 2 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| TAIHO ONCOLOGY, INC. | 2 | $62 |
| Karyopharm Therapeutics Inc. | 2 | $57 |
Products named: RYBREVANT, DARZALEX, OPDIVO, FOTIVDA, Enhertu, TAGRISSO, KISQALI, LONSURF.
Industry payments across CA — which companies pay providers there.
